Ácido docosahexaenoico (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ácido docosahexaenoico" in Galician language version.

refsWebsite

Global rank Galician rank

21doi.org

2^nd place

7^th place

21nih.gov

4^th place

6^th place

14web.archive.org

1^st place

2ajcn.org

low place

2,691^st place

2archive.org

6^th place

8^th place

2nutrition.org

7,878^th place

1,947^th place

1websters-online-dictionary.org

low place

1ebi.ac.uk

5,849^th place

619^th place

1martek.com

low place

1apa.org

1,220^th place

1,788^th place

1usda.gov

438^th place

385^th place

1medind.nic.in

low place

1springerlink.com

2,569^th place

747^th place

1fatsoflife.com

low place

1jbc.org

4,455^th place

611^th place

1dhaomega3.org

low place

1confex.com

6,094^th place

3,831^st place

1jneurosci.org

low place

2,905^th place

1clinicaltrials.gov

5,225^th place

7,257^th place

1alzheimersanddementia.com

low place

1marchofdimes.com

low place

1foodstandards.gov.au

low place

1wiley.com

222^nd place

134^th place

1fi.edu

low place

7,028^th place

1aappublications.org

3,763^rd place

3,502^nd place

1health.gov

low place

1nasa.gov

75^th place

47^th place

1fda.gov

447^th place

749^th place

1nytimes.com

7^th place

32^nd place

1worldcat.org

5^th place

11^th place

aappublications.org

pediatrics.aappublications.org

Ramakrishnan, Usha; et al. (8/01/11). "Prenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial". Journal of the American Academy of Pediatrics. doi:10.1542/peds.2010-1386.

ajcn.org

Giltay, E.J., Gooren, L. J. G., Toorians, A. W. F. T., Katan, M. B., & Zock, P. L. (2004). Docosahexanoic acid concentrations are higher in women than in men because of estrogenic effects. American Journal of Clinical Nutrition, 80(5), 1167-1174. Retrieved from http://www.ajcn.org/cgi/reprint/80/5/1167
Vedin I; et al. (1 June 2008). "Effects of docosahexaenoic acid–rich n–3 fatty acid supplementation on cytokine release". Am J Clin Nutr 87 (6): 1616–1622. PMID 18541548.

alzheimersanddementia.com

Karin Yurko-Mauroa, Deanna McCarthya, Dror Romb, Edward B. Nelsona, Alan S. Ryana, Andrew Blackwellc, Norman Salem Jr.a, Mary Stedman (03 May 2010). "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline". Arquivado dende o orixinal o 24 de setembro de 2019. Consultado o 28 de agosto de 2013.

apa.org

forms.apa.org

Malone, J. P. (2011, August). Autistogenesis: A systems theory with evolutionary perspective. Poster presented at the American Psychological Association 119th Annual Convention, Washington, D.C. Abstract retrieved from http://forms.apa.org/convention/viewabstract.cfm?id=110999 Arquivado 10 de marzo de 2014 en Wayback Machine..

archive.org

Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. (2001 Aug). "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention deficit/hyperactivity disorder". J Pediatr. 139 (2): 173–4. PMID 11487742. doi:10.1067/mpd.2001.116050.
Clandinin M, Van Aerde J, Merkel K, Harris C, Springer M, Hansen J, Diersen-Schade D (2005). "Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid". J Pediatr 146 (4): 461–8. PMID 15812447. doi:10.1016/j.jpeds.2004.11.030.

clinicaltrials.gov

National Institute on Aging (July 16, 2007). "DHA Phase 3 trial in Alzheimer's disease". Consultado o 10 de agosto de 2007.

confex.com

asa.confex.com

Malone, J. P. (2011, July). Autistogenesis: A systems theory with evolutionary perspective. Poster presented at the Autism Society, 41st National Conference, Orlando, Florida. Abstract retrieved from http://asa.confex.com/asa/2011/webprogram/Paper1750.html

dhaomega3.org

Sinn N, Bryan J. (2007 Apr). "Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD". J Dev Behav Pediatr. 28 (2): 139–44. PMID 17435458. doi:10.1097/01.DBP.0000267558.88457.a5.

doi.org

dx.doi.org

Guesnet P, Alessandri JM (2011). "Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations". Biochimie 93 (1): 7–12. PMID 20478353. doi:10.1016/j.biochi.2010.05.005.
British Journal of Nutrition, 88, 355-363. doi 10.1079/BJN2002662
Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. (2005 October). "A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease". J Clin Invest. 115 (10): 2774–83. PMC 1199531. PMID 16151530. doi:10.1172/JCI25420.
Serhan CN, Gotlinger K, Hong S, Arita M (2004). "Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis". Prostaglandins Other Lipid Mediat. 73 (3–4): 155–72. PMID 15290791. doi:10.1016/j.prostaglandins.2004.03.005.
McNamara RK; Hahn CG; Jandacek R; et al. (2007). "Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder". Biol. Psychiatry 62 (1): 17–24. PMID 17188654. doi:10.1016/j.biopsych.2006.08.026.
De Caterina, R and Basta, G (2001). "n-3 Fatty acids and the inflammatory response – biological background". European Heart Journal Supplements 3 (Supplement D): D42–D49. doi:10.1016/S1520-765X(01)90118-X.
Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. (2001 Aug). "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention deficit/hyperactivity disorder". J Pediatr. 139 (2): 173–4. PMID 11487742. doi:10.1067/mpd.2001.116050.
Sinn N, Bryan J. (2007 Apr). "Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD". J Dev Behav Pediatr. 28 (2): 139–44. PMID 17435458. doi:10.1097/01.DBP.0000267558.88457.a5.
Quinn JF; Raman R; Thomas RG; et al. (2010). "Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial". JAMA 304 (17): 1903–11. PMC 3259852. PMID 21045096. doi:10.1001/jama.2010.1510.
Matthew, Muldoon; Christopher M. Ryan, Lei Sheu, Jeffrey K. Yao, Sarah M. Conklin, and Stephen B. Manuck (January, 28). "Serum Phospholipid Docosahexaenonic Acid Is Associated with Cognitive Functioning during Middle Adulthood". Journal of Nutrition 140 (4): 848–53. PMC 2838625. PMID 20181791. doi:10.3945/jn.109.119578.
Kato T, Hancock RL, Mohammadpour H, McGregor B, Manalo P, Khaiboullina S, Hall MR, Pardini L, Pardini RS (2002). "Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice". Cancer Lett. 187 (1–2): 169–77. PMID 12359365. doi:10.1016/S0304-3835(02)00432-9.
Schønberg SA, Lundemo AG, Fladvad T, Holmgren K, Bremseth H, Nilsen A, Gederaas O, Tvedt KE, Egeberg KW, Krokan HE (2006). "Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1". Cancer Lett. 273 (12): 2749–65. PMID 16817902. doi:10.1111/j.1742-4658.2006.05292.x.
Shaikh IAA, Brown I, Schofield AC, Wahle KWJ, Heys SD (2008). "Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway". Prostate. 68 (15): 1635–1646. PMID 18668525. doi:10.1002/pros.20830.
Elmesery ME, Algayyar MM, Salem HA, Darweish MM, El-Mowafy AM (2009). "Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides". Cell Div 4 (1): 6. PMC 2680397. PMID 19341447. doi:10.1186/1747-1028-4-6.
Brasky, T. M.; Till, C.; White, E.; Neuhouser, M. L.; Song, X.; Goodman, P.; Thompson, I. M.; King, I. B.; Albanes, D. (2011). "Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial". American Journal of Epidemiology 173 (12): 1429–39. PMC 3145396. PMID 21518693. doi:10.1093/aje/kwr027.
Harnam, F; F. Shahidi (2004). "Synthesis of structured lipids via acidolysis of docosahexaenoic acid single-cell oil (DHASCO) with capric acid". J Agric Food Chem 52 (10): 2900–2906. PMID 15137833. doi:10.1021/jf035316f.
Clandinin M, Van Aerde J, Merkel K, Harris C, Springer M, Hansen J, Diersen-Schade D (2005). "Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid". J Pediatr 146 (4): 461–8. PMID 15812447. doi:10.1016/j.jpeds.2004.11.030.
Ramakrishnan, Usha; et al. (8/01/11). "Prenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial". Journal of the American Academy of Pediatrics. doi:10.1542/peds.2010-1386.
Sanders, Thomas A.B. (August–September 2009). "DHA status of vegetarians". Prostaglandins, Leukotrienes, and Essential Fatty Acids (International Society for the Study of Fatty Acids and Lipids) 81 (2–3): 137–141. ISSN 0952-3278. PMID 19500961. doi:10.1016/j.plefa.2009.05.013.
Crawford, M; et al. (2000). "Evidence for the unique function of docosahexaenoic acid (DHA) during the evolution of the modern hominid brain". Lipids 34 (S1): S39–S47. PMID 10419087. doi:10.1007/BF02562227.
Carlson BA, Kingston JD (2007). "Docosahexaenoic acid biosynthesis and dietary contingency: Encephalization without aquatic constraint". Am. J. Hum. Biol. 19 (4): 585–8. PMID 17546613. doi:10.1002/ajhb.20683.

ebi.ac.uk

CHEBI

fatsoflife.com

"DHA Deficit Detected in Frontal Cortex of Severely Depressed Patients" (PDF). PUFA Newsletter 12 (2): 14. 2007. Arquivado dende o orixinal (PDF) o 25 de abril de 2016. Consultado o 26 de xuño de 2019. Arquivado 25 de abril de 2016 en Wayback Machine.

fda.gov

"FDA: Why is there interest in adding DHA and ARA to infant formulas?". US Food & Drug Administration. Arquivado dende o orixinal o 18 de outubro de 2012. Consultado o xullo de 2002.

fi.edu

"Copia arquivada". Arquivado dende o orixinal o 26 de maio de 2011. Consultado o 28 de agosto de 2013. Arquivado 26 de maio de 2011 en Wayback Machine.

foodstandards.gov.au

"DHASCO and ARASCO in Infant Formula - Food Standards" (PDF). Arquivado dende o orixinal (PDF) o 16 de maio de 2005. Consultado o 16 de maio de 2005. Arquivado 16 de maio de 2005 en Wayback Machine.

health.gov

"(USDA)". Arquivado dende o orixinal o 06 de outubro de 2013. Consultado o 28 de agosto de 2013. Arquivado 06 de outubro de 2013 en Wayback Machine.

jbc.org

A Voss, M Reinhart, S Sankarappa and H Sprecher (1991). "The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase" (PDF). The Journal of Biological Chemistry 266 (30): 19995–20000. PMID 1834642. Consultado o 2 de xaneiro de 2011.

jneurosci.org

Lim, Giselle,; Frederic Calon; et al. (March 23, 2005). "A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model" (PDF). The Journal of Neuroscience.

marchofdimes.com

"Copia arquivada". Arquivado dende o orixinal o 22 de marzo de 2012. Consultado o 28 de agosto de 2013. Arquivado 22 de marzo de 2012 en Wayback Machine.

martek.com

aboutmartek.martek.com

Martek Biosciences Corporation (5 April 2007). "History of Martek". Arquivado dende o orixinal o 05 de febreiro de 2007. Consultado o March 10, 2007.

medind.nic.in

Meharban Singh (2005). "Essential Fatty Acids, DHA and the Human Brain from the Indian Journal of Pediatrics, Volume 72" (PDF). Arquivado dende o orixinal (PDF) o 27 de febreiro de 2012. Consultado o October 8, 2007. Arquivado 27 de febreiro de 2012 en Wayback Machine.

nasa.gov

sti.nasa.gov

Jones, John. "Nutritional Products from Space Research". May 1st, 2001. NASA. Arquivado dende o orixinal o 14 de febreiro de 2012. Consultado o 28 de agosto de 2013. Arquivado 14 de febreiro de 2012 en Wayback Machine.

nih.gov

ncbi.nlm.nih.gov

Guesnet P, Alessandri JM (2011). "Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations". Biochimie 93 (1): 7–12. PMID 20478353. doi:10.1016/j.biochi.2010.05.005.
Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. (2005 October). "A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease". J Clin Invest. 115 (10): 2774–83. PMC 1199531. PMID 16151530. doi:10.1172/JCI25420.
Serhan CN, Gotlinger K, Hong S, Arita M (2004). "Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis". Prostaglandins Other Lipid Mediat. 73 (3–4): 155–72. PMID 15290791. doi:10.1016/j.prostaglandins.2004.03.005.
McNamara RK; Hahn CG; Jandacek R; et al. (2007). "Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder". Biol. Psychiatry 62 (1): 17–24. PMID 17188654. doi:10.1016/j.biopsych.2006.08.026.
A Voss, M Reinhart, S Sankarappa and H Sprecher (1991). "The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase" (PDF). The Journal of Biological Chemistry 266 (30): 19995–20000. PMID 1834642. Consultado o 2 de xaneiro de 2011.
Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. (2001 Aug). "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention deficit/hyperactivity disorder". J Pediatr. 139 (2): 173–4. PMID 11487742. doi:10.1067/mpd.2001.116050.
Sinn N, Bryan J. (2007 Apr). "Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD". J Dev Behav Pediatr. 28 (2): 139–44. PMID 17435458. doi:10.1097/01.DBP.0000267558.88457.a5.
Quinn JF; Raman R; Thomas RG; et al. (2010). "Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial". JAMA 304 (17): 1903–11. PMC 3259852. PMID 21045096. doi:10.1001/jama.2010.1510.
Matthew, Muldoon; Christopher M. Ryan, Lei Sheu, Jeffrey K. Yao, Sarah M. Conklin, and Stephen B. Manuck (January, 28). "Serum Phospholipid Docosahexaenonic Acid Is Associated with Cognitive Functioning during Middle Adulthood". Journal of Nutrition 140 (4): 848–53. PMC 2838625. PMID 20181791. doi:10.3945/jn.109.119578.
Kato T, Hancock RL, Mohammadpour H, McGregor B, Manalo P, Khaiboullina S, Hall MR, Pardini L, Pardini RS (2002). "Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice". Cancer Lett. 187 (1–2): 169–77. PMID 12359365. doi:10.1016/S0304-3835(02)00432-9.
Schønberg SA, Lundemo AG, Fladvad T, Holmgren K, Bremseth H, Nilsen A, Gederaas O, Tvedt KE, Egeberg KW, Krokan HE (2006). "Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1". Cancer Lett. 273 (12): 2749–65. PMID 16817902. doi:10.1111/j.1742-4658.2006.05292.x.
Shaikh IAA, Brown I, Schofield AC, Wahle KWJ, Heys SD (2008). "Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway". Prostate. 68 (15): 1635–1646. PMID 18668525. doi:10.1002/pros.20830.
Elmesery ME, Algayyar MM, Salem HA, Darweish MM, El-Mowafy AM (2009). "Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides". Cell Div 4 (1): 6. PMC 2680397. PMID 19341447. doi:10.1186/1747-1028-4-6.
Brasky, T. M.; Till, C.; White, E.; Neuhouser, M. L.; Song, X.; Goodman, P.; Thompson, I. M.; King, I. B.; Albanes, D. (2011). "Serum Phospholipid Fatty Acids and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial". American Journal of Epidemiology 173 (12): 1429–39. PMC 3145396. PMID 21518693. doi:10.1093/aje/kwr027.
Harnam, F; F. Shahidi (2004). "Synthesis of structured lipids via acidolysis of docosahexaenoic acid single-cell oil (DHASCO) with capric acid". J Agric Food Chem 52 (10): 2900–2906. PMID 15137833. doi:10.1021/jf035316f.
Clandinin M, Van Aerde J, Merkel K, Harris C, Springer M, Hansen J, Diersen-Schade D (2005). "Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid". J Pediatr 146 (4): 461–8. PMID 15812447. doi:10.1016/j.jpeds.2004.11.030.
Sanders, Thomas A.B. (August–September 2009). "DHA status of vegetarians". Prostaglandins, Leukotrienes, and Essential Fatty Acids (International Society for the Study of Fatty Acids and Lipids) 81 (2–3): 137–141. ISSN 0952-3278. PMID 19500961. doi:10.1016/j.plefa.2009.05.013.
Vedin I; et al. (1 June 2008). "Effects of docosahexaenoic acid–rich n–3 fatty acid supplementation on cytokine release". Am J Clin Nutr 87 (6): 1616–1622. PMID 18541548.
Crawford, M; et al. (2000). "Evidence for the unique function of docosahexaenoic acid (DHA) during the evolution of the modern hominid brain". Lipids 34 (S1): S39–S47. PMID 10419087. doi:10.1007/BF02562227.
Carlson BA, Kingston JD (2007). "Docosahexaenoic acid biosynthesis and dietary contingency: Encephalization without aquatic constraint". Am. J. Hum. Biol. 19 (4): 585–8. PMID 17546613. doi:10.1002/ajhb.20683.

pubchem.ncbi.nlm.nih.gov

PubChem compound

nutrition.org

jn.nutrition.org

Matthew, Muldoon; Christopher M. Ryan, Lei Sheu, Jeffrey K. Yao, Sarah M. Conklin, and Stephen B. Manuck (January, 28). "Serum Phospholipid Docosahexaenonic Acid Is Associated with Cognitive Functioning during Middle Adulthood". Journal of Nutrition 140 (4): 848–53. PMC 2838625. PMID 20181791. doi:10.3945/jn.109.119578.
Jennifer Denomme, Ken D. Stark, and Bruce J. Holub (August 20, 2004). "Directly Quantitated Dietary (n-3) Fatty Acid Intakes of Pregnant Canadian Women Are Lower than Current Dietary Recommendations". Consultado o 9 de outubro de 2007.

nytimes.com

Rivlin, Gary (2007-01-14). "Magical or Overrated? A Food Additive in a Swirl". The New York Times. Consultado o 15-01-2007.

springerlink.com

Arthur A. Spector (1999). "Essentiality of Fatty Acids from Lipids, Vol. 34". Arquivado dende o orixinal o 24 de setembro de 2019. Consultado o October 8, 2007. Arquivado 24 de setembro de 2019 en Wayback Machine.

usda.gov

ars.usda.gov

Gary J. Nelson, Darshan S. Kelley. "DHA Lowers Blood Triglycerides in Diet Study" (PDF). Agricultural Research (USDA). Consultado o September 1998.

web.archive.org

"Copia arquivada". Arquivado dende o orixinal o 07 de xullo de 2013. Consultado o 28 de agosto de 2013.
Martek Biosciences Corporation (5 April 2007). "History of Martek". Arquivado dende o orixinal o 05 de febreiro de 2007. Consultado o March 10, 2007.
Martek Biosciences Corporation (29 July 2008). "Martek Products". Archived from the original on 30 de xaneiro de 2009. Consultado o July 29, 2008.
Malone, J. P. (2011, August). Autistogenesis: A systems theory with evolutionary perspective. Poster presented at the American Psychological Association 119th Annual Convention, Washington, D.C. Abstract retrieved from http://forms.apa.org/convention/viewabstract.cfm?id=110999 Arquivado 10 de marzo de 2014 en Wayback Machine..
Meharban Singh (2005). "Essential Fatty Acids, DHA and the Human Brain from the Indian Journal of Pediatrics, Volume 72" (PDF). Arquivado dende o orixinal (PDF) o 27 de febreiro de 2012. Consultado o October 8, 2007. Arquivado 27 de febreiro de 2012 en Wayback Machine.
Arthur A. Spector (1999). "Essentiality of Fatty Acids from Lipids, Vol. 34". Arquivado dende o orixinal o 24 de setembro de 2019. Consultado o October 8, 2007. Arquivado 24 de setembro de 2019 en Wayback Machine.
"DHA Deficit Detected in Frontal Cortex of Severely Depressed Patients" (PDF). PUFA Newsletter 12 (2): 14. 2007. Arquivado dende o orixinal (PDF) o 25 de abril de 2016. Consultado o 26 de xuño de 2019. Arquivado 25 de abril de 2016 en Wayback Machine.
Karin Yurko-Mauroa, Deanna McCarthya, Dror Romb, Edward B. Nelsona, Alan S. Ryana, Andrew Blackwellc, Norman Salem Jr.a, Mary Stedman (03 May 2010). "Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline". Arquivado dende o orixinal o 24 de setembro de 2019. Consultado o 28 de agosto de 2013.
"Copia arquivada". Arquivado dende o orixinal o 22 de marzo de 2012. Consultado o 28 de agosto de 2013. Arquivado 22 de marzo de 2012 en Wayback Machine.
"DHASCO and ARASCO in Infant Formula - Food Standards" (PDF). Arquivado dende o orixinal (PDF) o 16 de maio de 2005. Consultado o 16 de maio de 2005. Arquivado 16 de maio de 2005 en Wayback Machine.
"Copia arquivada". Arquivado dende o orixinal o 26 de maio de 2011. Consultado o 28 de agosto de 2013. Arquivado 26 de maio de 2011 en Wayback Machine.
"(USDA)". Arquivado dende o orixinal o 06 de outubro de 2013. Consultado o 28 de agosto de 2013. Arquivado 06 de outubro de 2013 en Wayback Machine.
Jones, John. "Nutritional Products from Space Research". May 1st, 2001. NASA. Arquivado dende o orixinal o 14 de febreiro de 2012. Consultado o 28 de agosto de 2013. Arquivado 14 de febreiro de 2012 en Wayback Machine.
"FDA: Why is there interest in adding DHA and ARA to infant formulas?". US Food & Drug Administration. Arquivado dende o orixinal o 18 de outubro de 2012. Consultado o xullo de 2002.

websters-online-dictionary.org

"Copia arquivada". Arquivado dende o orixinal o 07 de xullo de 2013. Consultado o 28 de agosto de 2013.

wiley.com

onlinelibrary.wiley.com

Developmental Medicine and Child Neurology, March 2000 http://onlinelibrary.wiley.com/doi/10.1111/j.1469-8749.2000.tb00066.x/pdf

worldcat.org

Sanders, Thomas A.B. (August–September 2009). "DHA status of vegetarians". Prostaglandins, Leukotrienes, and Essential Fatty Acids (International Society for the Study of Fatty Acids and Lipids) 81 (2–3): 137–141. ISSN 0952-3278. PMID 19500961. doi:10.1016/j.plefa.2009.05.013.